Influence of CYP2D6 activity on the disposition and cardiovascular toxicity of the antidepressant agent venlafaxine in humans.
Étienne Lessard(National Research Council Canada), Jacques Turgeon(Académie Nationale de Médecine), Gilles O’Hara(Institut universitaire de cardiologie et de pneumologie de Québec), Marie‐Andrée Yessine, Jacynthe LeBlanc, Bettina A. Hamelin
PubMed
August 1, 1999
Cited by 177
Related Papers
Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure
|New England Journal of Medicine|2008|1.6k
Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice
|Pharmaceutics|2020|237
Prevalence and Risk of Potential Cytochrome P450–Mediated Drug-Drug Interactions in Older Hospitalized Patients with Polypharmacy
|Annals of Pharmacotherapy|2013|186